cfDNA screening and diagnosis of monogenic disorders – where are we heading?

Cell‐free fetal DNA analysis for non‐invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use. Fetal monogenic diseases have also been shown to be amenable to non‐invasive detection by maternal plasma DNA analysis. A number of recent technological developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Eunice Ka Long, Hui, Winnie Wai In, Chiu, Rossa Wai Kwun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Special Topic Issue on Advances in the Diagnosis of Single Gene Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839244/
https://www.ncbi.nlm.nih.gov/pubmed/29314147
http://dx.doi.org/10.1002/pd.5207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839244/
https://www.ncbi.nlm.nih.gov/pubmed/29314147
http://dx.doi.org/10.1002/pd.5207

Ejemplares similares